Piramal Pharma Limited — Credit Ratings, 21-07-2025: Credit Rating- Revision

Piramal Pharma Limited's long-term credit ratings have been upgraded by CARE Ratings. The Long-term bank facilities, Issuer rating, and Non-convertible debentures are now rated CARE AA; Stable, up from CARE AA-; Positive. Simultaneously, the short-term bank facilities and commercial paper ratings have been reaffirmed at CARE A1+. This upgrade, accompanied by a stable outlook, generally signals enhanced creditworthiness. For the company, this implies a potential reduction in borrowing costs, which can improve financial flexibility. It also tends to bolster investor confidence in the company's financial stability and outlook.